Xanadu Quantum Technologies Ltd (XNDU): Financial results for Q2 2026
Xanadu Quantum Technologies Ltd (XNDU) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Xanadu Announces Second Quarter 2026 Results The Company is on a Mission to Build Quantum Computers That Are Useful and Available to People Everywhere TORONTO | August 5, 2026 /GLOBE NEWSWIRE/ -- Xanadu Quantum Technologies Limited ("Xanadu" or the "Company") (NASDAQ
How this was made
The 30-second read
Why it matters
The earnings release provides the first public disclosure of the quarter's financials, indicating a widening loss but a strong cash position, which may affect short‑term trading decisions.
Market read
Primary earnings disclosure for a niche quantum computing firm; relevant for traders tracking high‑tech and deep‑tech equities.
What to watch
Potential strategic partnerships with Oak Ridge, Rolls‑Royce, and Lockheed Martin may drive future revenue streams not reflected in current earnings.
Xanadu Announces Second Quarter 2026 Results
Revenue increased year over year but declined from the first quarter, while operating investment, capital expenditures and losses increased. The Company materially strengthened cash through its synthetic at-the-market facility but did not provide numerical financial guidance.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| RevenueGAAP | $1.5M | – | – |
| Cost of revenue (exclusive of depreciation and amortization below)GAAP | $128K | – | – |
| Research and developmentGAAP | $19.7M | $2.4 million increase | – |
| General and administrativeGAAP | approximately $11.1 million | – | – |
| Sales and marketingGAAP | $547K | – | – |
| Depreciation and amortizationGAAP | $1.64M | – | – |
| Other operating income, netGAAP | −$1.59M | – | – |
| Total operating expensesGAAP | $31.50M | – | – |
| Loss from operationsGAAP | −$29.99M | – | – |
| Interest income (expense), netGAAP | $2.32M | – | – |
| Loss on fair value of earn out share liabilities, netGAAP | −$10.60M | – | – |
| Loss on derivative instruments, netGAAP | −$1.91M | – | – |
| Other income (expense), netGAAP | −$1.88M | – | – |
| Total other income (expense), netGAAP | −$12.06M | – | – |
| Net lossGAAP | $42.1M | – | – |
| Net loss per share, basic and dilutedGAAP | $ (0.14) | – | – |
| Weighted average shares outstandingGAAP | 299,964,510 | – | – |
| Net comprehensive lossGAAP | −$41.60M | – | – |
| Adjusted EBITDAnon-GAAP | $21.3 million loss | – | – |
| Capital expendituresother | approximately $6.4 million | – | – |
Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.
Capital returns
- During the second quarter, the Company raised $67.2 million under the synthetic at-the-market facility, selling 5.5 million shares at an average net price of $12.28.
- The synthetic at-the-market equity facility with Yorkville Advisors is for up to $300 million over a three-year term.
What drove it
- The year-over-year revenue increase was primarily driven by DARPA Stage B revenue.
- R&D expense increased primarily because of increased spending on engineering hires.
- G&A expense increased primarily due to higher headcount, stock-based compensation, and capital market and public-company related professional costs.
- Adjusted EBITDA loss increased primarily due to increased R&D, G&A, and lower grant revenue in the quarter.
- The Company reported average edge-coupling loss of 0.085 dB per facet and increased foundry fabrication runs across thin-film lithium niobate, up approximately 75%, and silicon nitride, up approximately 50%.
Concerns
- Revenue was $1.5 million, compared to $2.8 million in the first quarter of 2026.
- Net loss was $42.1 million, compared to a loss of $20.6 million in the first quarter of 2026.
- The quarter included a $ (10,597) (In US $ thousands) loss on fair value of earn out share liabilities, net, and a $ (1,907) (In US $ thousands) loss on derivative instruments, net.
- The Company identified risks including significant technical challenges, potential need for additional future financing, concentration of revenue in contracts with government or state-funded entities, and potential substantial dilution from the equity line of credit.
What to watch
- More detailed engineering and spending guidance metrics, which the Company continues to expect to provide later this summer.
- Further growth of U.S. operations, where headcount has grown more than five-fold since 2023 and further growth is expected by year-end.
- The pace of drawing on the up to $300 million synthetic at-the-market equity facility.
- Continued foundry fabrication runs, wafer capacity investment, tapeouts, and engineering hires.
Balance sheet and cash flow
- Cash and cash equivalents were $312.8 million as of June 30, 2026.
- Cash and cash equivalents were $ 312,780 (In US $ thousands) as of June 30, 2026, compared with $ 16,164 (In US $ thousands) as of December 31, 2025.
- Current portion of long-term debt was $ 132 (In US $ thousands) as of June 30, 2026.
- Long-term debt was $ 32,407 (In US $ thousands) as of June 30, 2026, compared with $ 29,998 (In US $ thousands) as of December 31, 2025.
- Purchase of property and equipment, including equipment deposits ("capital expenditures") was $ (6,399) (In US $ thousands) for the six months ended June 30, 2026, compared with $ (4,320) (In US $ thousands) for the six months ended June 30, 2025.
Analysis
Xanadu reported $1.5 million of GAAP revenue in the second quarter ended June 30, 2026, compared with $2.8 million in the first quarter of 2026 and $1.1 million in the second quarter of 2025. The Company attributed the year-over-year increase primarily to DARPA Stage B revenue. The reported sequential revenue comparison and the statement that lower grant revenue contributed to the Adjusted EBITDA loss indicate a lower revenue contribution during the quarter than in Q1.
Operating investment increased. R&D expense was $19.7 million, up $2.4 million from the first quarter, primarily reflecting engineering hires. G&A expense was approximately $11.1 million versus $9.8 million in the prior quarter, driven by headcount, stock-based compensation, and capital-market and public-company professional costs. Capital expenditures rose to approximately $6.4 million from $0.3 million in the first quarter, consistent with the Company's stated investment in engineering talent and wafer capacity.
Profitability deteriorated, with a GAAP net loss of $42.1 million versus a $20.6 million loss in Q1 and an Adjusted EBITDA loss of $21.3 million versus a $13.9 million loss. The GAAP results also included a $ (10,597) (In US $ thousands) loss on fair value of earn out share liabilities, net, and a $ (1,907) (In US $ thousands) loss on derivative instruments, net. Loss from operations was $ (29,991) (In US $ thousands), compared with $ (15,523) (In US $ thousands) in the prior-year quarter.
Liquidity increased materially following financing activity. Cash and cash equivalents were $312.8 million as of June 30, 2026, versus $ 16,164 (In US $ thousands) at December 31, 2025. Xanadu raised $67.2 million under its Yorkville synthetic at-the-market facility during the quarter by selling 5.5 million shares at an average net price of $12.28, while noting the facility can provide up to $300 million over three years. The Company gave no numerical financial outlook, instead stating it expects to provide more detailed engineering and spending guidance metrics later this summer.
The operating milestones focused on photonic component performance, fabrication capacity, software releases and collaborations. Xanadu reported average edge-coupling loss of 0.085 dB per facet, foundry fabrication-run increases across its two core material platforms, and expanded U.S. operations. The primary items for investors to monitor are the timing and detail of forthcoming spending guidance, revenue progression including grant revenue, the pace of R&D and capital spending, and further use of the equity facility.
Management, verbatim
This quarter, we made real progress on that mission. We set new performance records across some of our core photonic components, and we're pairing that hardware progress with software breakthroughs that we believe make quantum algorithms more efficient today.
Dr. Christian Weedbrook, Founder and Chief Executive Officer of Xanadu
That balance sheet gives us the runway to keep investing in the engineering talent and wafer capacity our roadmap requires.
Michael Trzupek, Chief Financial Officer of Xanadu
Not in the filing
stated, not guessed- Gross profit and gross margin
- Segment revenue and segment profitability
- Operating cash flow
- Free cash flow
- Income tax expense or benefit and tax rate
- Formal numerical revenue, gross-margin, operating-expense, or tax-rate guidance
- Share repurchases
- Dividend declaration or payment
- Prior-quarter GAAP earnings per share
- Prior-quarter operating loss
- Prior-quarter total operating expenses
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Xanadu Quantum Technologies, a publicly listed photonic quantum computing company on Nasdaq and TSX, filed a Form 6‑K earnings release for Q2 2026.
Ticker impact
Xanadu Quantum Technologies reported Q2 2026 earnings, revealing $312.8M cash, $1.5M revenue and a $42.1M net loss.
Potential modest downside pressure as investors digest larger loss and higher cash burn.
The company disclosed a larger net loss than the prior quarter and elevated R&D spend, which may weigh on the stock despite a strong cash position.
Market effects
Highlights ongoing capital needs in the quantum computing sector and may influence investor sentiment toward other photonic quantum firms.
Limited to North American investors; no broader regional effect.
Modest, as quantum computing remains a niche market with limited immediate macro impact.
Counterpoint
The sizable cash reserve could enable accelerated development, positioning Xanadu for a breakthrough that justifies a premium.
Key entities
- ExecutiveChristian Weedbrook
Founder and CEO of Xanadu, quoted on company progress.
- ExecutiveMichael Trzupek
CFO, provided cash and financing details.
